H Tejada Meza1,2,3, Á Lambea Gil3,4, C Villar Yus1,3, C Pérez Lázaro3, M P Navarro Pérez3,4, I Campello Morer5, Á Giménez Muñoz5, J Artal Roy6, O Alberti González6, N Hernando Quintana7, P Ruiz Palomino7, J A Crespo Burillo8, C García Arguedas8, L Ballester Marco9, M Palacin Larroy10, M Seral Moral10, J Marta Moreno1,3. 1. Sección de Neurovascular, Servicio de Neurología, Hospital Universitario Miguel Servet, Zaragoza, España. 2. Unidad de Neurointervencionismo, Servicio de Radiología, Hospital Universitario Miguel Servet, Zaragoza, España. 3. Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, España. 4. Servicio de Neurología, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España. 5. Servicio de Neurología, Hospital Royo Villanova, Zaragoza, España. 6. Servicio de Neurología, Hospital San Jorge, Huesca, España. 7. Servicio de Neurología, Hospital Obispo Polanco, Teruel, España. 8. Servicio de Neurología, Hospital de Barbastro, Barbastro, Huesca, España. 9. Servicio de Neurología, Hospital de Alcañiz, Alcañiz, Teruel, España. 10. Servicio de Neurología, Hospital Ernest Lluch, Calatayud, Zaragoza, España.
Abstract
INTRODUCTION: The COVID-19 pandemic has had an impact on ischaemic stroke management, with a reported decrease in hospital admissions, and even disruptions in healthcare and increased in-hospital mortality. However, there is a lack of evidence on the impact of the pandemic on functional prognosis. The aim of this study is to analyse the effect of the COVID-19 pandemic on the 3-month functional outcomes of patients hospitalised due to acute ischaemic stroke in Aragon (Spain). MATERIL AND METHODS: We reviewed the data of all patients admitted due to ischaemic stroke to any hospital in our regional healthcare system between 30 December 2019 and 3 May 2020. We compared modified Rankin Scale scores and mortality at 3 months in patients hospitalised before and after the declaration of a state of emergency due to the COVID-19 pandemic. RESULTS: In total, 318 patients with acute ischaemic stroke met our inclusion criteria. No differences were observed between periods in global or specific characteristics, with the exception of a higher proportion of patients older than 80 years during the first period (42.2% vs. 29.0%, P=.028). In the comparative analysis, we found no significant differences in mortality (12.3 vs. 7.9, P=.465) or in the proportion of patients with modified Rankin Scale scores ≤ 2 (57.7% vs. 57.1%, P=.425) at 3 months. CONCLUSION: To our knowledge, this is the first study to analyse the impact of COVID-19 pandemic on the 3-month functional outcomes of patients with ischaemic stroke. In our region, there has been no increase in rates of mortality or disability at 3 months in patients admitted due to ischaemic stroke during the pandemic.
INTRODUCTION: The COVID-19 pandemic has had an impact on ischaemic stroke management, with a reported decrease in hospital admissions, and even disruptions in healthcare and increased in-hospital mortality. However, there is a lack of evidence on the impact of the pandemic on functional prognosis. The aim of this study is to analyse the effect of the COVID-19 pandemic on the 3-month functional outcomes of patients hospitalised due to acute ischaemic stroke in Aragon (Spain). MATERIL AND METHODS: We reviewed the data of all patients admitted due to ischaemic stroke to any hospital in our regional healthcare system between 30 December 2019 and 3 May 2020. We compared modified Rankin Scale scores and mortality at 3 months in patients hospitalised before and after the declaration of a state of emergency due to the COVID-19 pandemic. RESULTS: In total, 318 patients with acute ischaemic stroke met our inclusion criteria. No differences were observed between periods in global or specific characteristics, with the exception of a higher proportion of patients older than 80 years during the first period (42.2% vs. 29.0%, P=.028). In the comparative analysis, we found no significant differences in mortality (12.3 vs. 7.9, P=.465) or in the proportion of patients with modified Rankin Scale scores ≤ 2 (57.7% vs. 57.1%, P=.425) at 3 months. CONCLUSION: To our knowledge, this is the first study to analyse the impact of COVID-19 pandemic on the 3-month functional outcomes of patients with ischaemic stroke. In our region, there has been no increase in rates of mortality or disability at 3 months in patients admitted due to ischaemic stroke during the pandemic.
Authors: Herbert Tejada Meza; Álvaro Lambea Gil; Agustín Sancho Saldaña; Maite Martínez-Zabaleta; Patricia de la Riva Juez; Elena López-Cancio Martínez; María Castañón Apilánez; María Herrera Isasi; Juan Marta Enguita; Mercedes de Lera Alfonso; Juan F Arenillas; Jon Segurola Olaizola; Juan José Timiraos Fernández; Joaquín Sánchez; Mar Castellanos-Rodrigo; Alexia Roel; Ignacio Casado Menéndez; Mar Freijo; Alain Luna Rodriguez; Enrique Palacio Portilla; Yésica Jiménez López; Emilio Rodríguez Castro; Susana Arias Rivas; Javier Tejada García; Iria Beltrán Rodríguez; Francisco Julián-Villaverde; Maria Pilar Moreno García; José María Trejo-Gabriel-Galán; Ana Echavarría Iñiguez; Carlos Tejero Juste; Cristina Pérez Lázaro; Javier Marta Moreno Journal: Int J Stroke Date: 2020-06-26 Impact factor: 5.266
Authors: B Fuentes; M Alonso de Leciñana; P Calleja-Castaño; J Carneado-Ruiz; J Egido-Herrero; A Gil-Núñez; J Masjuán-Vallejo; J Vivancos-Mora; J Rodríguez-Pardo; N Riera-López; Á Ximénez-Carrillo; A Cruz-Culebras; C Gómez-Escalonilla; E Díez-Tejedor Journal: Neurologia (Engl Ed) Date: 2020-05-21
Authors: Joan Montaner; Ana Barragán-Prieto; Soledad Pérez-Sánchez; Irene Escudero-Martínez; Francisco Moniche; José Antonio Sánchez-Miura; Lidia Ruiz-Bayo; Alejandro González Journal: Stroke Date: 2020-05-29 Impact factor: 7.914
Authors: H Tejada Meza; Á Lambea Gil; A Sancho Saldaña; M Martínez-Zabaleta; E Garmendia Lopetegui; E López-Cancio Martínez; M Castañón Apilánez; M Herrera Isasi; J Marta Enguita; B Gómez-Vicente; J F Arenillas; N Arenaza Basterrechea; J J Timiraos Fernández; J Sánchez Herrero; J L Maciñeiras Montero; M Castellanos Rodrigo; D Fernández-Coud; I Casado Menéndez; M T Temprano Fernández; M Freijo; A Luna; E J Palacio Portilla; Y Jiménez López; E Rodríguez-Castro; M Rodríguez-Yáñez; J Tejada García; I Beltrán Rodríguez; F Julián-Villaverde; M P Moreno García; J M Trejo Gabriel-Galán; A Echavarría Iñiguez; C Pérez Lázaro; M P Navarro Pérez; J Marta Moreno Journal: Eur J Neurol Date: 2020-09-04 Impact factor: 6.288